Depo-Provera contraceptive lawsuits to be consolidated in Northern District of Florida
About 70 federal lawsuits alleging that the injectable contraceptive Depo-Provera causes an increased risk of developing a type of brain tumor will be consolidated in the Northern District of Florida, a judicial panel decided on Feb. 7.
Defendants in these cases, including Pfizer Inc. and other pharmaceutical companies, had favored the centralization of the cases in the Southern District of New York, according to the U.S. Judicial Panel on Multidistrict Litigation’s transfer order.
“Pfizer Inc., Pharmacia & Upjohn Co. LLC and Pharmacia LLC support centralization in the Southern District of New York or, alternatively, before a judge in the eastern United States with experience deciding important threshold motions in a large mass-tort MDL,” the panel said.

Navigation 